Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2005
|
| _version_ | 1826281023006048256 |
|---|---|
| author | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D |
| author_facet | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D |
| author_sort | Isaacs, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:22:32Z |
| format | Conference item |
| id | oxford-uuid:7d0c5253-2e0a-432d-9441-fab3af539adc |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:22:32Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:7d0c5253-2e0a-432d-9441-fab3af539adc2022-03-26T21:00:52ZLong-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritisConference itemhttp://purl.org/coar/resource_type/c_5794uuid:7d0c5253-2e0a-432d-9441-fab3af539adcSymplectic Elements at Oxford2005Isaacs, JClarke, AHazleman, BHale, GWaldmann, HSymmons, D |
| spellingShingle | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title | Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_full | Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_fullStr | Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_full_unstemmed | Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_short | Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_sort | long term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| work_keys_str_mv | AT isaacsj longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT clarkea longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT hazlemanb longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT haleg longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT waldmannh longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT symmonsd longtermsurvivalafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis |